Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
about
The use of lentinan for treating gastric cancerLentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapyPhase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerA phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimenIrinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer.Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma.S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapyLogistic regression analysis for febrile neutropenia (FN) induced by docetaxel in Japanese cancer patients.Recent developments in the treatment of gastric carcinoma.A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.Status of treatment for advanced gastric carcinoma.The role of chemotherapy in the current treatment of gastric cancer.Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas.Palliative chemotherapy for advanced gastric cancer.Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.Recent developments in the systemic therapy of advanced gastroesophageal malignancies.Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.Docetaxel-associated epiphora.Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma.Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer.Docetaxel in the treatment of gastric cancer.Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer.A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma.Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.Review of docetaxel in the treatment of gastric cancer.Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.Chemotherapy for metastatic disease: review from JCOG trials.Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen.
P2860
Q24619416-478D6BB9-46BE-4E7D-A64D-17D98F4D826FQ24635111-1D12F229-97BE-4F18-ADE2-8EEB01104FE9Q24810562-B2750AA7-D912-434E-A020-05874EDDC49CQ28350903-9635322D-3DEA-48B7-9E40-130466A6D434Q33180637-46135855-EEC9-4460-9080-86523929CB29Q33341264-E70AF10F-4799-4BA1-BD07-93BC1D80989AQ33349888-F78353EC-E935-42EA-999E-E6B8C033CEF1Q33385867-8182ED78-E3E3-48CF-900F-863ADEB12359Q33403949-72B18651-D9F1-4196-92F2-79DD206DC3EFQ33415440-125232C7-F83B-41EC-ABAD-93597D4FFA20Q33594906-2FD96F05-3875-4A65-8397-E53F3B98C343Q34159161-DB22BBD1-B73F-4ABE-935A-D99A5623B2DFQ34585843-5BA9BD8B-A0E1-4A7A-88B7-1B1E2367DAC7Q34590788-2AD0C3D5-8FEF-4BED-BB83-5A55701CD342Q34620042-6BEF0274-4B0A-40A8-B339-8CC0AC7DB946Q35095365-3D0CC471-9049-4E72-A379-B9DFA65B9D5CQ35139161-8240CEF2-0C9D-4F4E-8B3D-752C35182006Q35181089-CB3CA829-CA86-4AFD-ADD2-6841058FE49CQ35936039-F9AC3D1F-07D9-4882-A8FF-A1F3D5872F7DQ36295002-F021CF4B-8A2C-4B8F-B976-0626EE327500Q36376439-3FF3D1A4-79A4-446A-9858-8A64C5AC81D4Q36396339-BBE3742E-71E5-4B7D-9CED-CB74F0E5A97EQ36459767-DD825826-FFC7-408F-A8E7-6EC7BFF5616CQ36484970-35070CEC-2907-469D-9D20-28DC17D70712Q36548725-26EA31F1-6F53-413C-A552-0003D32A26E4Q36611262-4ECF7A9D-A475-4761-9C90-D193B8C379A3Q36614148-F965FEA5-523A-4F31-9A14-3FB55BFF9BD9Q36614394-2D9373BC-6E89-4686-87D2-08A6CA95EA22Q36614734-ABB90D0F-3800-415A-80A2-097F6ACCA1DCQ36615597-151C36F7-0A38-43D6-A572-9C9E0E951A8AQ36616308-67A4438D-10D0-4AD9-AFE2-D8E7520E656BQ36616503-67DD6891-4A2D-47D5-8578-F684B3D9EA92Q36625990-8801C554-446D-4FDB-8E96-80C6162548CDQ36674440-F96FCF96-5961-4341-8806-356B4A924332Q36795339-1770606A-5F76-41A9-84DD-8F3053F6E022Q36853997-BC763F71-0C14-43D6-B21D-0A58AE4FFA1FQ37052880-C132DD7E-4178-4078-A724-7D1D13183621Q37077239-6DE95785-7F89-42DF-8392-67CCCA873E9EQ37191094-C3548375-C66E-49AD-95D5-8CC76FBA0B06Q37214866-783AAA45-9131-4FC4-9DAD-A9290263867A
P2860
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@ast
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@en
type
label
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@ast
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@en
prefLabel
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@ast
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@en
P2093
P2860
P356
P1476
Docetaxel (Taxotere) in advanc ...... C Early Clinical Trials Group.
@en
P2093
H Franklin
J B Vermorken
P2860
P2888
P304
P356
10.1038/BJC.1994.310
P407
P577
1994-08-01T00:00:00Z